Navigating complexities and considerations for suspected anastomotic leakage in the upper gastrointestinal tract: A state of the art review

被引:2
|
作者
Kamarajah, Sivesh K. [1 ]
Markar, Sheraz R. [2 ]
机构
[1] Univ Birmingham, Inst Appl Hlth Res, Dept Global Hlth & Surg, Birmingham, England
[2] Univ Oxford, Nuffield Dept Surg, Surg Intervent Trials Unit, Oxford, England
关键词
Anastomotic leak; Oesophagectomy; Gastrectomy; Surgical treatment; Risk factors; VACUUM-ASSISTED CLOSURE; PERIOPERATIVE CHEMOTHERAPY; SURGICAL-TREATMENT; OPEN-LABEL; ESOPHAGECTOMY; MANAGEMENT; MULTICENTER; DIAGNOSIS; IMPACT; CANCER;
D O I
10.1016/j.bpg.2024.101916
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This state-of-the-art review explores the intricacies of anastomotic leaks following oesophagectomy and gastrectomy, crucial surgeries for globally increasing esophageal and gastric cancers. Despite advancements, anastomotic leaks occur in up to 30 % and 10 % of oesophagectomy and gastrectomy cases, respectively, leading to prolonged hospital stays, substantial impact upon short- and long-term health-related quality of life and greater mortality. Recognising factors contributing to leaks, including patient characteristics and surgical techniques, are vital for preoperative risk stratification. Diagnosis is challenging, involving clinical signs, biochemical markers, and various imaging modalities. Management strategies range from non-invasive approaches, including antibiotic therapy and nutritional support, to endoscopic interventions such as stent placement and emerging vacuum-assisted closure devices, and surgical interventions, necessitating timely recognition and tailored interventions. A step-up approach, beginning non-invasively and progressing based on treatment success, is more commonly advocated. This comprehensive review highlights the absence of standardised treatment algorithms, emphasizing the importance of individualised patient-specific management.
引用
收藏
页数:4
相关论文
共 41 条
  • [41] Sustained complete response to first-line immunochemotherapy for highly aggressive TP53/MDM2-mutated upper tract urothelial carcinoma with ERBB2 mutations, luminal immune-infiltrated contexture, and non-mesenchymal state: a case report and literature review
    Xu, Tianyuan
    Guo, Hanxu
    Xie, Jun
    He, Yanyan
    Che, Jianping
    Peng, Bo
    Yang, Bin
    Yao, Xudong
    FRONTIERS IN ONCOLOGY, 2023, 13